Picture of Cansino Biologics logo

6185 Cansino Biologics Balance Sheet

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for Cansino Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:PROSPECTUSPROSPECTUSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments4211977555,1147,783
Net Total Accounts Receivable
Net Total Receivables2.6715.123.1136631
Total Inventory
Total Other Current Assets
Total Current Assets4272217945,4219,290
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment3975076089172,317
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets8667961,7846,74811,874
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1131071244132,875
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities2592943146773,879
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Total Equity6075021,4716,0717,995
Total Liabilities & Shareholders' Equity8667961,7846,74811,874
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email